Literature DB >> 12825792

Classification scheme for the design of serine protease targeted compound libraries.

Stanley A Lang1, Andrey V Kozyukov, Konstantin V Balakin, Andrey V Skorenko, Andrey A Ivashchenko, Nikolay P Savchuk.   

Abstract

The development of a scoring scheme for the classification of molecules into serine protease (SP) actives and inactives is described. The method employed a set of pre-selected descriptors for encoding the molecular structures, and a trained neural network for classifying the molecules. The molecular requirements were profiled and validated by using available databases of SP- and non-SP-active agents [1,439 diverse SP-active molecules, and 5,131 diverse non-SP-active molecules from the Ensemble Database (Prous Science, 2002)] and Sensitivity Analysis. The method enables an efficient qualification or disqualification of a molecule as a potential serine protease ligand. It represents a useful tool for constraining the size of virtual libraries that will help accelerate the development of new serine protease active drugs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12825792     DOI: 10.1023/a:1023832728547

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  6 in total

1.  Molecular recognition in the post-reductionist era.

Authors:  M H Van Regenmortel
Journal:  J Mol Recognit       Date:  1999 Jan-Feb       Impact factor: 2.137

2.  Conformational selection of inhibitors and substrates by proteolytic enzymes: implications for drug design and polypeptide processing.

Authors:  D P Fairlie; J D Tyndall; R C Reid; A K Wong; G Abbenante; M J Scanlon; D R March; D A Bergman; C L Chai; B A Burkett
Journal:  J Med Chem       Date:  2000-04-06       Impact factor: 7.446

Review 3.  Protease inhibitors: current status and future prospects.

Authors:  D Leung; G Abbenante; D P Fairlie
Journal:  J Med Chem       Date:  2000-02-10       Impact factor: 7.446

4.  A scoring scheme for discriminating between drugs and nondrugs.

Authors:  J Sadowski; H Kubinyi
Journal:  J Med Chem       Date:  1998-08-27       Impact factor: 7.446

5.  Can we learn to distinguish between "drug-like" and "nondrug-like" molecules?

Authors:  A Ajay; W P Walters; M A Murcko
Journal:  J Med Chem       Date:  1998-08-27       Impact factor: 7.446

Review 6.  The urokinase-type plasminogen activator system in cancer metastasis: a review.

Authors:  P A Andreasen; L Kjøller; L Christensen; M J Duffy
Journal:  Int J Cancer       Date:  1997-07-03       Impact factor: 7.396

  6 in total
  1 in total

1.  High content image-based screening of a protease inhibitor library reveals compounds broadly active against Rift Valley fever virus and other highly pathogenic RNA viruses.

Authors:  Rajini Mudhasani; Krishna P Kota; Cary Retterer; Julie P Tran; Chris A Whitehouse; Sina Bavari
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.